GLP-1 medications can still be highly effective during this stage, but expectations must adjust
The International Diabetes Federation projects that the global diabetes population will reach 783 million by 2045, creating a growing clinical market for GLP-1 therapies that extends across the entire forecast period
Results May Vary Individual results will vary based on factors including age, baseline weight, metabolic health, consistency of medication use, lifestyle factors (diet, physical activity, sleep), genetic factors, current medications, and other individual variables
Key points: Surgery showed stronger results Ozempic still helps many patients Cost and safety affect treatment choice When Should You Talk to Passion Health Advanced Primary Care